Foxconn to use proceeds from unit's Shanghai IPO to fund US$4b projects
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[HONG KONG] Taiwan's Foxconn, the world's largest contract electronics manufacturer, said it plans to use proceeds from a Shanghai listing of one if its subsidiaries to fund eight projects totalling US$4 billion.
In January, Foxconn, formally known as Hon Hai Precision Industry Co, said its shareholders had approved a plan to list its subsidiary, Foxconn Industrial Internet Co Ltd (FII), on the Shanghai Stock Exchange.
FII said in a listing prospectus to the China Securities Regulatory Commission late on Friday that the eight projects were focused on building smart manufacturing platforms, cloud computing services and 5G solutions.
FII, which makes electronic devices, cloud service equipmen+t and industrial robots, did not provide details on the size or timing of the initial public offering.
A Hon Hai unit, China Galaxy Enterprises Limited, directly and indirectly owns 69 per cent of FII that was founded in March 2015, according to the prospectus.
China International Capital Corporation is the sponsor and lead underwriter for the IPO.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
FII made a net profit of 16.2 billion yuan (S$3.41 billion yuan) in 2017, according to the filing, representing a compounded annual growth rate of 6.32 per cent from 14.4 billion yuan in 2015.
Revenue reached 354.5 billion yuan last year, representing an annual growth of 14 per cent from 2015.
FII said its main clients include Amazon, Apple , ARRIS, Cisco, Dell, HPE, Huawei , Lenovo, NetApp, Nokia and nVidia.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant